LeMaitre Vascular faces challenges including the discontinuation of ASIO, which impacted revenues, and the fallout from a catheter recall.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LeMaitre Vascular faces challenges including the discontinuation of ASIO, which impacted revenues, and the fallout from a catheter recall.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
LeMaitre Vascular (United States)
company in Burlington, United States
-
ASIO
company in Brno, Czech Republic
Nothing else this week.
-
China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
Coverage
Newest first; wire copies grouped- GuruFocus.comLeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the full ear